Alexion Pharmaceuticals+Image

0

Alexion Pharmaceuticals

243 Known

243

Answers

49

Metrics

13

Years

Metric	Answer Year
5 Company Reporting Guidelines Research	Yes - SASB Yes - GRI, Yes - IR, Yes - SASB, Yes - Ot 2020
0 S&P 500 Index Research	Yes Yes, No 2020
7 Headquarters Location Formula	Connecticut (United States) Abu Dhabi (United Arab Emirates), Afghani 2019
3 Country Formula	United States Afghanistan, Albania, Algeria, Andorra, A 2019
3 Good Will Research	5.04B USD 2019
3 Unrecognized Tax Benefits Reductions Resulting from Lapse of Applicable statute of Limitations Research	1.2M USD 2019
2 Comprehensive Income Net of Tax Research	2.35B USD 2019
2 Current Income Tax Expense Benefit Research	230M USD 2019
2 Net Income Attributable to the company Research	2.4B USD 2019
1 Assets Research	17.5B USD 2019
1 Cost of Goods and Services Sold Research	395M USD 2019
1 Current Foreign Tax Expense Benefit Research	158M USD 2019
1 Deferred Income Tax Expense Benefit Research	-456M USD 2019
1 Effective Income Tax Rate Continuing Operations Research	-0.1 2019
1 Income Loss From Continuing Operations Before Income Taxes Foreign Research	2.18B USD 2019
1 Research and Development Expense Research	886M USD 2019
0 CEO pay Research	15.3M USD 2019
0 CEO to Worker Pay Ratio Research	92 :1 2019
0 Domestic Income Tax Expense/Benefit Formula	71.8M 2019
0 Excess CEO Pay (%) Research	13.8 % 2019

Export: csv / json

Headquarters

Connecticut (United States)

SEC CIK

0000899866

Integrations

Wikipedia

Opencorporates

Content is available under the Creative Commons- Attribution 4.0 International License; additional terms may apply. See Terms of Use for details.

WikiRate is a registered trademark of The WikiRate Project e.V., a nonprofit organization based in Berlin, Germany.

Legal: Privacy Policy | Licensing | Disclaimers | Terms of Use | Notice Powered by Decko